🇺🇸 Aglicid in United States

FDA authorised Aglicid on 22 June 1961

Marketing authorisations

FDA — authorised 22 June 1961

  • Status: approved

FDA — authorised 10 July 1974

  • Application: NDA012678
  • Marketing authorisation holder: SANDOZ
  • Local brand name: TOLBUTAMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 30 January 1979

  • Application: ANDA086109
  • Marketing authorisation holder: WATSON LABS
  • Local brand name: TOLBUTAMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 20 November 1979

  • Application: ANDA086047
  • Marketing authorisation holder: PARKE DAVIS
  • Local brand name: TOLBUTAMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 25 March 1980

  • Application: ANDA087093
  • Marketing authorisation holder: ANI PHARMS
  • Local brand name: TOLBUTAMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 4 June 1980

  • Application: ANDA086574
  • Marketing authorisation holder: CHARTWELL RX
  • Local brand name: TOLBUTAMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 20 February 1981

  • Application: ANDA087121
  • Marketing authorisation holder: BARR
  • Local brand name: TOLBUTAMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 5 October 1983

  • Application: ANDA087541
  • Marketing authorisation holder: ASCOT
  • Local brand name: TOLBUTAMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 19 November 1984

  • Application: ANDA088893
  • Marketing authorisation holder: SUPERPHARM
  • Local brand name: TOLBUTAMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 19 March 1985

  • Application: ANDA087876
  • Marketing authorisation holder: VANGARD
  • Local brand name: TOLBUTAMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA088950
  • Marketing authorisation holder: PUREPAC PHARM
  • Local brand name: TOLBUTAMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Aglicid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United States

Frequently asked questions

Is Aglicid approved in United States?

Yes. FDA authorised it on 22 June 1961; FDA authorised it on 10 July 1974; FDA authorised it on 30 January 1979.

Who is the marketing authorisation holder for Aglicid in United States?

Marketing authorisation holder not available in our data.